Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes
US10865419B2 · kind B2 · utility
0Cited by
13References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 24, 2012 |
| Grant date | Dec 15, 2020 |
| Priority date | — |
| Expiry date | Dec 16, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for treating Type II diabetes. The compositions comprise plant expressed Exendin 4. Particularly exemplified are plant derived compositions that include a CTB-EX4 conjugate that is bioencapsulated in chloroplasts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.